Effects of Seaweed Extract on Blood Glucose Response to Sucrose

NCT ID: NCT05461560

Last Updated: 2022-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-05

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine the impact of the seaweed (Ascophyllum nodosum) extract on blood glucose levels after a sugary drink in healthy subjects.

The aim of this study is to investigate if the seaweed extract, when consumed with the sucrose, can lower blood glucose levels, compared to the raise after sucrose only, in healthy volunteers.

The study is designed as an acute, double-blind, randomised, controlled crossover trial in 16 healthy subjects. Participants will be asked to consume sucrose solution or sucrose solution with added seaweed extract.The effects on blood glucose levels will be determined over 2 hours after the consumption.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Blood glucose levels after a meal rich in sugars depend, among other factors, on the activity of enzymes that digest sugar molecules to glucose. Epidemiological studies suggest that glucose levels after a meal higher than normal, present a great risk for the onset of cardiovascular diseases. Slowing the digestion of sugar through the inhibition of digestion enzymes have been demonstrated as a successful approach in preventing postprandial hyperglycaemia either with pharmacological agents (acarbose, miglitol) or natural dietary compounds.

We demonstrated, in preclinical in vitro experiments, the unique potential of tested seaweed extract to inhibit rat sucrase.

This study will examine the potential of the seaweed extract to modulate blood glucose levels after a sucrose drink in healthy subjects .

The aim of this study is to investigate if the seaweed extract, when consumed with sucrose, can lower blood glucose levels, compared to the raise after sucrose only.

The study is designed as an acute, double-blind, randomised, controlled crossover trial in 16 healthy subjects. Participants will be asked to consume sucrose solution or sucrose solution with added seaweed extract.The effects on blood glucose levels (in capillary blood) will be determined over 2 hours after the consumption. All participants will be characterized for the activity of salivary a-amylase

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose Intolerance Diabetes Mellitus, Type 2 Healthy Diet Postprandial Hyperglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control: Sucrose solution

Participants will consume 50g of sucrose dissolved in 500 ml of tap water

Group Type SHAM_COMPARATOR

Sucrose solution

Intervention Type DIETARY_SUPPLEMENT

50 g of sucrose dissolved in 500 ml of tap water

Experimental: Seaweed extract in sucrose solution

Participants will consume 50g of sucrose and 1g of seaweed extract dissolved in 500 ml of tap water

Group Type EXPERIMENTAL

Seaweed extract in sucrose solution

Intervention Type DIETARY_SUPPLEMENT

1 g of seaweed extract in solution of 50 g of sucrose in 500 ml of tap water

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sucrose solution

50 g of sucrose dissolved in 500 ml of tap water

Intervention Type DIETARY_SUPPLEMENT

Seaweed extract in sucrose solution

1 g of seaweed extract in solution of 50 g of sucrose in 500 ml of tap water

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-60 years
* Healthy

Exclusion Criteria

* Smoking
* Diagnosis of any chronic illness (including diabetes, hypertension, gastrointestinal diseases etc.)
* On long term prescribed medication (except contraceptives)
* Pregnant or lactating
* On a special diet or dietary regimen (for weight management or if regularly consuming fruit extract supplements)
* Allergy to fruits vegetables, pollen or seaweed.
* Unwillingness to follow dietary recommendations or record the diet during recommended period
* Donated blood 4 weeks before or intend to donate blood during the study or 4 weeks after the last study samples
* Participation in another research project in parallel which also involves dietary intervention (e.g. taking vitamin supplements) or requires sampling of blood
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University College Dublin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Akristic

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Food and Health Volunteer Suite; Science Center South, UCD

Dublin, Dublin 2, Ireland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aleksandra Konic Ristic, PhD

Role: CONTACT

+ 353 1 7162504

Eileen Gibney, PhD

Role: CONTACT

+ 353 1 7162819

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aleksandra Konic Ristic, PhD

Role: primary

+ 353 1 7162504

Eileen Gibney, PhD

Role: backup

+ 353 1 7162819

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LS-21-54

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

THC Effects on Glucose in Type 2 Diabetes
NCT05322213 RECRUITING PHASE1
Olive Leaf Extracts in the Control of Diabet
NCT05605704 RECRUITING PHASE2/PHASE3
BSE on Blood Glucose
NCT03763240 COMPLETED NA